Excelente presentación de panorama de la terapia sistémica perioperatoria en MIBC por Andrea Necchi en #CAU2022 — momento y esquemas aun en plena investigación. Toxicidad sigue siendo prioridad en etapas iniciales

#CAU22 Day 2/last day for me. Enjoying rising star Michael Poch lecture on TURBT quality in bladder cancer Confederación Americana de Urología (CAU) Philippe spiess Global Society of Rare GU Tumors

Another situation I feel very critical: CSI nonseminoma, high risk. Right side baseline CT scan vs repeat CT scan (left) post 2 months prior to decide what to do. Should we revise the initial timing of image assessment in CSI? Global Society of Rare GU Tumors Philippe spiess Rob Hamilton

Very important and timely topic. Just one case of ours to challenge your guidelines: 25yo, testicular ECA, intermediate prognosis for HCG >5K, retroperitoneal mass the only site. BEPx4 > major response STM negative. RPLND or Surveillance? Philippe spiess Global Society of Rare GU Tumors Daniele Raggi

Role of neoadjuvant chemotherapy in #UTUC Stephen Boorjian, MD Alejandro Rodriguez Rafael Sanchez-Salas Confederación Americana de Urología (CAU) #CAU22

Let’s start my #CAU22 meeting with Stephen Boorjian, MD lecture on management of #UTUC . Moderation by Rafael Sanchez-Salas Great start! Confederación Americana de Urología (CAU) Global Society of Rare GU Tumors Alejandro Rodriguez

I am speaking at CAU 2022. Please check out my talk if you're attending the event! #CAU2022 - via #Whova event app

Headed to Cancun for my talk at Confederación Americana de Urología (CAU) #CAU2022 I am interested to know your opinion. What is the key player in neoadjuvant>adjuvant therapy translation from trials to practice for muscle invasive #bladdercancer UroToday.com Global Society of Rare GU Tumors ASCO ESMO - Eur. Oncology European Association of Urology (EAU) Uni San Raffaele Ospedale San Raffaele

Neoadjuvant Pembrolizumab->Radical Cystectomy for Muscle-Invasive #bladdercancer -Andrea Necchi-36-month RFS associated with path stage (<ypT2N0 ~96%); EFS associated with PD-L1-high, claudin-low, basal/squamous subtype-comment Tim Clinton prac.co/l/24feqcuy PracticeUpdate

Check out the GSRGT Journal Club! youtu.be/E632ozBclY4

Laura Marandino MD_Bandini Ben Ayres Philippe spiess discuss a global 🌍 approach to improving penile cancer care

🔑 message: We NEED international collaboration!

Please do not miss the media coverage of the first Global Society of Rare GU Tumors virtual Journal Club: A global approach to improving penile cancer. Outstanding contributions by Laura Marandino Ben Ayres MD_Bandini and the President Philippe spiess 👉 youtu.be/E632ozBclY4

Happy to see such talented fellows conquering the stages. In the name of #Neoadjuvant #immunotherapy Congratulations Giuseppe_Basile #PURE01 #SIU22 Uni San Raffaele Ospedale San Raffaele UroToday.com Global Society of Rare GU Tumors

Watch Axel S. Merseburger Bradley McGregor and Andrea Necchi summarize and interpret the latest data from the ESMO - Eur. Oncology cONGRESS 2022 on immunotherapies and targeted treatments for bladder cancer.

This activity was filmed during the ESMO Congress 2022.

Watch now: bit.ly/3SW4ffm